ALPHA TAU MEDICAL LTD. (DRTS)
Alpha Tau Successfully Treats First Recurrent Glioblastoma Patient Outside of the United States with Alpha DaRT® at Hadassah University Medical Center in Israel
Alpha Tau Successfully Treats First Recurrent Glioblastoma Patient Outside of the United States with Alpha DaRT® at Hadassah University Medical Center in Israel
Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Advancing Nanoparticle-Encapsulated PNKP Inhibitor in Oncology Space
Esquire Financial Holdings, Inc. and Signature Bancorporation Inc. Announce Final Exchange Ratio for Proposed Merger
SoundThinking Announces SafetySmart® Field Agent™; the New AI Layer for Connected Platform Intelligence
DiaMedica Therapeutics Announces First Patients Dosed in Phase 2 Trial of DM199 for the Treatment of Fetal Growth Restriction
Disclosure of Interest/Changes in Interest of Substantial Shareholder(s)/Unitholder(s)::Disclosure of Change in Interest of Substantial Shareholders-Coop International & Bonvests Holdings
SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury
NASDAQ: ENSG Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages The Ensign Group, Inc. (NASDAQ: ENSG) Investors to Contact the Firm
EHang Selected for Hong Kong’s “Low-Altitude Economy Regulatory Sandbox X” Trial Projects
SRX Global Makes Strategic Investment in Clinical-Stage Biodefense Company, ARMR Sciences